ask="74.25"
ask_size="200"
average_daily_volume="572463"
bid="N/A"
bid_size="N/A"
book_value="11.38"
change="-0.18"
change_from_200_day_moving_average="1.42"
change_from_50_day_moving_average="-2.10"
change_from_52_week_high="-16.91"
change_From_52_week_low="23.34"
change_in_percent="-0.26%"
close="69.86"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="71.38"
high_52_weeks="86.77"
last_trade_date="1/25/2017"
last_trade_price="69.86"
last_trade_size="14566"
last_trade_time="4:00pm"
low="69.14"
low_52_weeks="46.52"
market_capitalization="2.85B"
moving_average_200_day="68.44"
moving_average_50_day="71.96"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="70.95"
pe_ratio="N/A"
peg_ratio="-0.38"
percent_change_from_200_day_moving_average="+2.07%"
percent_change_from_50_day_moving_average="-2.92%"
percent_change_from_52_week_high="-19.49%"
percent_change_from_52_week_low="+50.17%"
previous_close="70.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.15"
price_per_sales="22359.13"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="10.26"
stock_exchange="NMS"
symbol="RARE"
volume="213878"
weeks_range_52="46.52 - 86.77"
